OMER
OMER
NASDAQ · Pharmaceuticals

Omeros Corp

$20.08
+1.59 (+8.60%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +224.6% upside
Low Target $47.12
Average Target $65.17
High Target $100.64
Current Price $20.08
Current
$20.08
Target
$65.17
$47.12 $65.17 avg $100.64
Scenario Analysis
Bear Case
$47.12
134.7%
Low target
Base Case
$65.17
+224.6%
Avg target
Bull Case
$100.64
+401.2%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$19.65
2.2% from high
52-Week Low
$3.94
+409.6% from low
Target vs 52W High
$65.17
+231.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.8%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.1%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.0%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.6%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%